Patent · US Expired

Therapeutic method

US6869926B1 · kind B1 · utility

2Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 25, 1998
Grant dateMar 22, 2005
Priority date
Expiry dateSep 25, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/84
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new therapeutic use of amylin as agent which stimulates chondrocyte proliferation and which therefore have utility in the treatment of cartilage disorders and/or cartilage mediated bone growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.